Download PDF
CC BY-NC-ND 4.0 · Indian Journal of Neurosurgery 2022; 11(03): 210-215
DOI: 10.1055/s-0041-1735352
Original Article

Spontaneous Intraparenchymal Hemorrhage in Patients with COVID-19: A Prospective Study and Literature Review

Hannan Ebrahimi
1   Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran
,
Hadi Digaleh
1   Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran
,
Ahmad Pour-Rashidi 
1   Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran
,
Vahid Kazemi
1   Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran
,
Azar Hadadi
2   Department of Infectious Disease, Sina Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran
,
Shahin Nasseri
1   Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran
,
Farshid Mirzaii
1   Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran
,
Abolghasem Mortazavi
1   Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran
,
Abbas Amirjamshidi 
1   Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Introduction Coronavirus disease 2019 (COVID-19) is a devastating pandemic that may also affect the nervous system. One of its neurological manifestations is intracerebral hemorrhage (ICH). Data about pure spontaneous intraparenchymal hemorrhage related to COVID-19 is scarce. In this study, we present some patients with COVID-19 disease who also had spontaneous intraparenchymal hemorrhage along with a review of the literature.

Methods This single-center prospective study was done among 2,862 patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) between March 1 and November 1, 2020. Out of 2,862 patients with SARS-CoV-2, 14 patients with neurological manifestations were assessed with a noncontrast brain computed tomography scan. Seven patients with spontaneous intraparenchymal hemorrhage were enrolled.

Results All seven patients were male, with a mean age of 60.8 years old. Six patients (85.7%) only had minimal symptoms of COVID-19 without significant respiratory distress. The level of consciousness in two patients (28.5%) was less than eight, according to the Glasgow Coma Scale (GCS). Hypertension (71.4%) was the most common risk factor in their past medical history. The mean volume of hematoma was 41cc. Four patients died during hospitalization, and the others were discharged with a mean hospital stay of 42.6 days. All patients with GCS less than 11 died.

Conclusion It concluded that ICH patients with COVID-19 are related to higher blood volume, cortical and subcortical location of hemorrhage, higher fatality rate, and younger age that is different to spontaneous ICH in general population. We recommend more specific neuroimaging in patients with COVID 19 such as brain magnetic resonance imaging concomitant with vascular studies in future. The impact of COVID-19 on mortality rate is not clear because of limited epidemiologic studies, but identifying the causal relationship between COVID-19 and ICH requires further clinical and laboratory studies.

Keywords

coronavirus - COVID-19 - intracerebral hemorrhage - spontaneous intraparenchymal hemorrhage


Publication History

Article published online:
15 December 2021

© 2021. Neurological Surgeons’ Society of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Fatehi P, Hesam-Shariati N, Abouzaripour M, Fathi F, Hesam Shariati MB. Acute ischemic and hemorrhagic stroke and COVID-19: case series. SN Compr Clin Med 2020; (e-pub ahead of print). DOI: DOI: 10.1007/s42399-020-00559-8.
    CrossrefPubMedGoogle Scholar
  • 2 Poggiali E, Bastoni D, Ioannilli E, Vercelli A, Magnacavallo A. Deep vein thrombosis and pulmonary embolism: two complications of COVID-19 pneumonia?. Eur J Case Rep Intern Med 2020; 7 (05) 001646
    PubMedGoogle Scholar
  • 3 Coronavirus disease (COVID-19) pandemic. (2020). Accessed June 24, 2021 at https://www.who.int/emergencies/diseases/novel-coronavirus-2019
    PubMed
  • 4 Gogia B, Fang X, Rai P. Intracranial hemorrhage in a patient with COVID-19: possible explanations and considerations. Cureus 2020; 12 (08) e10159
    PubMedGoogle Scholar
  • 5 Pavlov V, Beylerli O, Gareev I, Torres Solis LF, Solís Herrera A, Aliev G. COVID-19-related intracerebral hemorrhage. Front Aging Neurosci 2020; 12: 600172
    CrossrefPubMedGoogle Scholar
  • 6 Mao L, Jin H, Wang M. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77 (06) 683-690
    CrossrefPubMedGoogle Scholar
  • 7 Melmed KR, Cao M, Dogra S. et al. Risk factors for intracerebral hemorrhage in patients with COVID-19. J Thromb Thrombolysis 2021; 51 (04) 953-960
    CrossrefPubMedGoogle Scholar
  • 8 Dogra S, Jain R, Cao M. et al. Hemorrhagic stroke and anticoagulation in COVID-19. J Stroke Cerebrovasc Dis 2020; 29 (08) 104984
    CrossrefPubMedGoogle Scholar
  • 9 Kvernland A, Kumar A, Yaghi S. et al. Anticoagulation use and hemorrhagic stroke in SARS-CoV-2 patients treated at a New York Healthcare System. Neurocrit Care 2021; 34 (03) 748-759
    CrossrefPubMedGoogle Scholar
  • 10 Altschul DJ, Unda SR, de La Garza Ramos R. et al. Hemorrhagic presentations of COVID-19: risk factors for mortality. Clin Neurol Neurosurg 2020; 198: 106112
    CrossrefPubMedGoogle Scholar
  • 11 Nawabi J, Morotti A, Wildgruber M. et al. Clinical and imaging characteristics in patients with SARS-CoV-2 infection and acute intracranial hemorrhage. J Clin Med 2020; 9 (08) 2543
    CrossrefPubMedGoogle Scholar
  • 12 Mousa-Ibrahim F, Berg S, Od TPDetola O, Teitcher M, Ruland S. Intracranial hemorrhage in hospitalized SARS-CoV-2 patients: a case series. J Stroke Cerebrovasc Dis 2021; 30 (01) 105428
    CrossrefPubMedGoogle Scholar
  • 13 Benger M, Williams O, Siddiqui J, Sztriha L. Intracerebral haemorrhage and COVID-19: clinical characteristics from a case series. Brain Behav Immun 2020; 88: 940-944
    CrossrefPubMedGoogle Scholar
  • 14 Hernández-Fernández F, Sandoval Valencia H, Barbella-Aponte RA. et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain 2020; 143 (10) 3089-3103
    CrossrefPubMedGoogle Scholar
  • 15 Fayed I, Pivazyan G, Conte AG, Chang J, Mai JC. Intracranial hemorrhage in critically ill patients hospitalized for COVID-19. J Clin Neurosci 2020; 81: 192-195
    CrossrefPubMedGoogle Scholar
  • 16 Ghani MU, Kumar M, Ghani U, Sonia F, Abbas SA. Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients. J Neurovirol 2020; 26 (04) 602-604
    CrossrefPubMedGoogle Scholar
  • 17 Carroll E, Lewis A. Catastrophic intracranial hemorrhage in two critically ill patients with COVID-19. Neurocrit Care 2021; 34 (01) 354-358
    CrossrefPubMedGoogle Scholar
  • 18 Morassi M, Bagatto D, Cobelli M. et al. Stroke in patients with SARS-CoV-2 infection: case series. J Neurol 2020; 267 (08) 2185-2192
    CrossrefPubMedGoogle Scholar
  • 19 Sweid A, Hammoud B, Bekelis K. et al. Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019. Int J Stroke 2020; 15 (07) 733-742
    CrossrefPubMedGoogle Scholar
  • 20 de Oliveira Manoel AL, Goffi A, Zampieri FG. et al. The critical care management of spontaneous intracranial hemorrhage: a contemporary review. Crit Care 2016; 20: 272 DOI: 10.1186/s13054-016-1432-0.
    CrossrefPubMedGoogle Scholar
  • 21 Zheng H, Chen C, Zhang J, Hu Z. Mechanism and therapy of brain edema after intracerebral hemorrhage. Cerebrovasc Dis 2016; 42 (3-4) 155-169
    CrossrefPubMedGoogle Scholar
  • 22 Howard G, Cushman M, Howard VJ. et al. Risk factors for intracerebral hemorrhage: the REasons for geographic and racial differences in stroke (REGARDS) study. Stroke 2013; 44 (05) 1282-1287
    CrossrefPubMedGoogle Scholar
  • 23 Flaherty ML, Woo D, Haverbusch M. et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke 2005; 36 (05) 934-937
    CrossrefPubMedGoogle Scholar